Group 1 - The core viewpoint of the news is that Jianfan Bio (300529.SZ) reported a decrease in institutional investor holdings in its A-shares, with a total of 51.87 million shares held by six institutions, representing 6.49% of the total share capital, down by 2.00 percentage points from the previous quarter [1] Group 2 - In the public fund sector, two public funds increased their holdings, including Huabao Zhongzheng Medical ETF and Southern Zhongzheng 500 ETF, with an increase ratio of 0.25% [2] - Two public funds decreased their holdings, namely, Zhaoshang Guozhen Biomedical Index A and Yifangda Growth Enterprise ETF, with a decrease ratio of 0.11% [2] - Six public funds did not disclose their holdings in the current period, including Guangda Baodexin Credit Enhancement Bond A and others [2] Group 3 - Regarding foreign investment, the Hong Kong Central Clearing Limited is noted as an institution that did not disclose its holdings in the current period [3]

公募基金方面，本期较上一期持股增加的公募基金共计22个，主要包括创新药、天弘国证生物医药 ETF、招商国证生物医药指数A、国泰中证生物医药ETF、广发创新药ETF等，持股增加占比达0.16%。 本期较上一季度持股减少的公募基金共计6个，主要包括华泰柏瑞沪深300ETF、摩根中证创新药产业 ETF、嘉实中证疫苗与生物技术ETF、广发创新药ETF联接A、华夏医药ETF等，持股减少占比达 0.11%。本期较上一季度新披露的公募基金共计189个，主要包括易方达沪深300医药ETF、易方达沪深 300ETF、华夏沪深300ETF、嘉实沪深300ETF、华安上证180ETF等。本期较上一季未再披露的公募基 金共计5个，包括富国中证医药50ETF、博时医药50ETF、易方达中证创新药产业ETF联接发起式A、富 国中证医药50ETF联接A、国泰中证沪港深创新药产业ETF发起联接A。 2025年4月12日，万泰生物(603392.SH)发布2024年年度报告。截至2025年4月11日，共有219个机构投资 者披露持有万泰生物A股股份，合计持股量达7.78亿股，占万泰生物总股本的61.50%。其中，前十大机 构投资者包括养生堂有 ...

Group 1 - The core viewpoint of the news is that as of March 27, 2025, institutional investors hold a significant portion of Tiger Medical's A-shares, totaling 1.76 billion shares, which accounts for 20.31% of the company's total equity [1] - The top ten institutional investors collectively hold 14.86% of Tiger Medical's shares, with a decrease of 1.43 percentage points compared to the previous quarter [1] Group 2 - In the public fund sector, two funds increased their holdings, while five funds decreased their holdings, with a total reduction rate of 0.19% [2] - A total of 16 new public funds were disclosed this period, including notable funds such as E Fund CSI 300 Medical ETF and others [2] - One foreign fund, Hong Kong Central Clearing Limited, reduced its holdings by 0.30% compared to the previous quarter [2]